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Introduction. Obesity has become a serious public health problem in most industrialized 
countries, affecting a growing segment of the population.  
Aim of the study. Study of etiopathogenetic factors, consequences and strategies of obesity 
treatment in Moldova and Israel.  
Materials and methods. 220 patients overweight were evaluated in 2017 aged 40-79. I used the 
questionnaire to investigate clinical cases.  
Results. Our group is made up of 30% male subjects and the vast majority of 70% of female 
subjects. 76% of the subjects in the control group claim 3-5 meals per day, 13% consume 2-3 
meals / day and only 14% - between 5-7 meals / dayIt is noticed that 55% of patients have a 
sedentary activity at work 40% of people were diagnosed but dyslipidemia, 20% with diabetes, 
15% with hypertension, and 25% with associated diseases. It was found that 37% of patients 
were treated with Orlistat and 19% with Lorcaserin, of which 49% of patients treated with 
Orlistat and 40% of patients treated with Lorcaserin lost ≥ 10% of baseline body weight after 6 
months of treatment, the mean weight difference between these preparations being 3.2 kg.  
Conclusions. Obesity is associated with numerous complications, such as dyslipidemia, 
diabetes, hypertension, etc. After 6 months of treatment, the mean difference in weight loss of 
Orlistat and Lorcaserin was 3.2 kg.  
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Introduction. In the Republic of Moldova atopic dermatitis to children is increasing as in other 
countries and the prevalence of this disease has increased from 11.9% in 2006, to 19.6% 
children, in 2016.  
Aim of the study. Elucidation of the contemporary aspects of etiological, clinical and pharmaco-
therapeutic features of atopic dermatitis to children.  
Materials and methods. The analysis of 97 cases of atopic dermatitis to children for 2 years, 
which were addressed to family doctors at the polyclinics. 
Results. Of the study group with atopic dermatitis, it was established that 42.5% belonged to the 
extrinsic subtype of atopic dermatitis to children, and 57.5% of the patients belonged to the 
intrinsic subtype. To 3% of children is the mild form of evolution, in 35% of cases the evolution 
is average and in 52% serious cases. Of the group of children which were included in study, 11 
have other associated allergic diseases (27%), respectively 8 with allergic rhinitis (20%) and 3 
with bronchial asthma (7.5%). Glucocorticosteroids are first-line remedies in topical treatment of 
atopic dermatitis, such as mometasone, clobetasol and fluticasone creams. Of the first generation 
of antihistamines,such as clemastine, chloropiramine and ciproheptadine are prescribed with pre-
selection in acute forms of the disease. In subacute and chronic forms, second-and third-
generation antihistamines are generally used. 
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Conclusions. Glucocorticosteroids are indicated for children with moderate, severe or recurrent 
forms of atopic dermatitis to children. Generations of antihistamines of the first generation are 
prescribed with predelection in acute forms, while second- and third-generation antihistamines 
are used in subacute and chronic forms.  
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Introduction. Parkinson's disease is a slowly progressive neurologic disease that is characterized 
by a fixed inexpressive face, tremor at rest, slowdown of voluntary movements, gait with short 
accelerating steps, peculiar posture and muscle weakness, and low production of the 
neurotransmitter dopamine. It has a prevalence of about 1 per 1,000, reaching 1 in 200 in the 
elderly, estimated to affect over 6.4 million people worldwide, so far no case can be established 
and healing it. The incidence of Parkinson's disease in the Republic of Moldova has not been the 
subject of epidemiologic research, and is not on the list of statistically reported diseases.  
Aim of the study. Analyse the frequency of Parkinson's disease, the causes of its occurrence, and 
to establish treatment methods according to the etiology of the disease as well as highlighting the 
latest treatment methods.  
Materials and methods. The study includes a complex research of Parkinson's pharmacotherapy 
based on the analysis of the observation files of patients in the Vascular and Extrapyramidal 
Neurology Department of the Institute of Neurology and Neurosurgery. An analysis of the 
observation sheets and the indication sheets of 50 patients with Parkinson's disease diagnosed 
and hospitalized during 2017. From each patient's file, the following data were taken for 
analysis: sex, age, background, medical and surgical treatment principles, discharge 
recommendations.  
Results. According to the processed data, we can see that Parkinson's disease is manifested in 
both female patients 22 (44%) and male patients 28 (56%). According to age prevalence, the 
majority of investigated patients belong to the age range of 66-75 years, in total 21 cases (42%); 
followed by 56-65 years-16 cases (32%). The lowest prevalence is represented by the age of 76-
85 years - 3 cases. In rural areas, the prevalence is higher (60%) than urban (40%).  
Conclusions. Despite the extraordinary progress of neuroscience, PD etiopathogenesis remains a 
mystery. There are several factors that interact, or more, processes that influence or contribute to 
BP pathogenesis. After performing the study, we found that Parkinson's disease is manifested in 
both sexes, and most patients fall into the age of 66-75 years. In depending on the environment 
of origin, there are more patients in rural areas. There is no treatment to stop the destruction of 
the nerve cells that lead to this condition. However, some medicines can relieve the symptoms of 
the disease.  
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